Geriatric Screening and CARG chemotherapy toxicity assessment tools were found in a study to predict adverse outcomes in older patients with cancer.
Acupuncture was associated with improvements in symptoms and quality of life.
Rusfertide demonstrated activity in reducing hematocrit levels in patients with polycythemia vera in two phase 2 clinical trials.
There was no significant difference in survival outcomes with trabectedin or physician’s choice of chemotherapy.
Rivoceranib produced responses whether or not patients had received prior treatment with a VEGFR TKI.
A study showed the predictive value of Eastern Cooperative Oncology Group performance status in a real-world cohort of patients.
Researchers compared preoperative patient care methods to find a method that could improve advance directive completion rates in patients undergoing surgery for newly diagnosed breast cancer.
A pilot study delegated screening assessments to nurse navigators to determine if such a program would increase referrals to supportive services for older older patients.
Researchers sought to determine whether adding rituximab to axicabtagene ciloleucel would have efficacy in patients with refractory large B-cell lymphoma.
A survey of men with prostate cancer sought to identify when these patients were most vulnerable to symptoms of depression and/or anxiety.
Researchers sough to determine whether zanubrutinib would improve responses compared with ibrutinib in patients with Waldenström macroglobulinemia.
Preliminary results of a clinical trial investigating the efficacy of CAR-T therapy in pediatric patients with CD7+ ALL/lymphoma were presented at ASCO 2022.
Trastuzumab deruxtecan improved progression-free and overall survival, compared with physician’s choice of therapy.
Gender balance in cancer surveys was found to have relatively little effect on survey outcomes, according to results of a study presented at the 2022 ASCO Annual Meeting. Surveying patients with myeloproliferative neoplasms (MPN) has given valuable insight into polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) subtypes. However, independent surveys have included a…
Researchers found that socioeconomic status, insurance, race, and rurality were all associated with telemedicine use.
Ifosfamide improved event-free and overall survival.
More than 80% of Black survey respondents said they were somewhat or very likely to consider enrolling in a clinical trial.
A 10% increase in public welfare spending was associated with an 8.6% improvement in 5-year overall survival for Black patients with cancer.